CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue	$ 608,181	$ 27,111	$ 3,976
Costs and expenses
Cost of revenue	1,646,086	154,897	3,070
Research and development	821,512	750,185	511,110
Selling, general and administrative	734,574	652,475	89,023
Total cost and expenses	3,202,172	1,557,557	603,203
Loss from operations	(2,593,991)	(1,530,446)	(599,227)
Other income (expense), net
Change in fair value of forward contracts	0	(454,546)	(118,382)
Transaction costs expensed	0	(2,717)	0
Interest income	56,756	0	0
Interest expense	(30,596)	(1,374)	(64)
Other income (expense), net	9,532	(893)	(690)
Total other income (expense), net	1,289,910	(1,049,266)	(120,341)
Loss before provision for (benefit from) income taxes	(1,304,081)	(2,579,712)	(719,568)
Provision for (benefit from) income taxes	379	49	(188)
Net loss	(1,304,460)	(2,579,761)	(719,380)
Deemed dividend related to the issuance of Series E convertible preferred stock	0	(2,167,332)	0
Net loss attributable to common stockholders, basic	(1,304,460)	(4,747,093)	(705,596)
Change in fair value of dilutive warrants	(1,254,218)	0	0
Net loss attributable to common stockholders, diluted	$ (2,558,678)	$ (4,747,093)	$ (705,596)
Weighted average shares outstanding used in computing net loss per share attributable to common stockholders, basic (in shares)	1,678,346,079	740,393,759	24,825,944
Weighted average shares outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares)	1,693,258,608	740,393,759	24,825,944
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.78)	$ (6.41)	$ (28.42)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (1.51)	$ (6.41)	$ (28.42)
Other comprehensive loss
Net unrealized losses on investments, net of tax	$ (11,572)	$ 0	$ 0
Comprehensive loss	(1,316,032)	(2,579,761)	(719,380)
Deemed dividend related to the issuance of Series E convertible preferred stock	0	(2,167,332)	0
Comprehensive loss attributable to common stockholders	(1,316,032)	(4,747,093)	(705,596)
Series B
Other income (expense), net
Deemed contribution related to repurchase of convertible preferred stock	0	0	1,000
Other comprehensive loss
Deemed contribution related to repurchase of convertible preferred stock	0	0	1,000
Series C
Other income (expense), net
Deemed contribution related to repurchase of convertible preferred stock	0	0	12,784
Other comprehensive loss
Deemed contribution related to repurchase of convertible preferred stock	0	0	12,784
Change in fair value of convertible preferred stock warrant liability
Other income (expense), net
Change in fair value of stock warrants liability	0	(6,976)	(1,205)
Change in fair value of common stock warrant liability
Other income (expense), net
Change in fair value of stock warrants liability	$ 1,254,218	$ (582,760)	$ 0